BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 19644070)

  • 1. High-sensitivity C-reactive protein and lipoprotein-associated phospholipase A2 stability before and after stroke and myocardial infarction.
    Elkind MS; Leon V; Moon YP; Paik MC; Sacco RL
    Stroke; 2009 Oct; 40(10):3233-7. PubMed ID: 19644070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between the D166E polymorphism of the lipoprotein associated phospholipase A2 and risk of myocardial infarction.
    Zhang MM; Zhang CG; Yang CJ; Zhao P; Li YL
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3960-3966. PubMed ID: 31115024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Use of Lipoprotein-Associated Phospholipase A2 in a Chinese Population to Predict Cardiovascular Events.
    Xi H; Cheng GL; Hu FF; Li SN; Deng X; Zhou Y
    Biomed Environ Sci; 2022 Mar; 35(3):206-214. PubMed ID: 35317900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma lipoprotein-associated phospholipase A2 mass is elevated in STEMI compared to non-STEMI patients but does not discriminate between myocardial infarction and non-cardiac chest pain.
    Dullaart RP; van Pelt LJ; Kwakernaak AJ; Dikkeschei BD; van der Horst IC; Tio RA
    Clin Chim Acta; 2013 Sep; 424():136-40. PubMed ID: 23756128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum lipoprotein-associated phospholipase A2 predicts the formation of carotid artery plaque and its vulnerability in anterior circulation cerebral infarction.
    Yang Y; Xue T; Zhu J; Xu J; Hu X; Wang P; Kong T; Yan Y; Yang L; Xue S
    Clin Neurol Neurosurg; 2017 Sep; 160():40-45. PubMed ID: 28644968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of lipoprotein-associated phospholipase A
    Han L; Zhong C; Bu X; Xu T; Wang A; Peng Y; Xu T; Wang J; Peng H; Li Q; Ju Z; Geng D; Zhang Y; He J;
    Atherosclerosis; 2017 Nov; 266():1-7. PubMed ID: 28934604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein-Associated Phospholipase A2 and Risk of Carotid Atherosclerosis and Cardiovascular Events in Community-Based Older Adults in China.
    Wang C; Fang X; Hua Y; Liu Y; Zhang Z; Gu X; Wu X; Tang Z; Guan S; Liu H; Liu B; Guo X; Ji X
    Angiology; 2018 Jan; 69(1):49-58. PubMed ID: 28429599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease.
    Sabatine MS; Morrow DA; O'Donoghue M; Jablonksi KA; Rice MM; Solomon S; Rosenberg Y; Domanski MJ; Hsia J;
    Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2463-9. PubMed ID: 17766330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of Lipoprotein-Associated Phospholipase A
    Tibuakuu M; Kianoush S; DeFilippis AP; McEvoy JW; Zhao D; Guallar E; Ballantyne CM; Hoogeveen RC; Blaha MJ; Michos ED
    Am J Cardiol; 2018 May; 121(9):1056-1064. PubMed ID: 29525060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers for Prediction of Cardiovascular Events in Community-Dwelling Adults Aged 40 or Older.
    Chong Y; Ren Q; Li Y; Li C; Feng F; Zhou Y
    Int Heart J; 2020 Jan; 61(1):109-114. PubMed ID: 31875617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between the serum lipoprotein-associated phospholipase A
    Dong L; Tong J; Fan S
    Cardiovasc J Afr; 2023 Nov-Dec 23; 34(5):273-277. PubMed ID: 36637451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein phospholipase A2 mass and activity are not associated with the diagnosis of acute brain ischemia.
    Tai W; Garcia M; Mlynash M; Kemp S; Albers GW; Olivot JM
    Cerebrovasc Dis; 2014; 38(5):324-7. PubMed ID: 25428761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in lipoprotein-Associated phospholipase A2 activity predict coronary events and partly account for the treatment effect of pravastatin: results from the Long-Term Intervention with Pravastatin in Ischemic Disease study.
    White HD; Simes J; Stewart RA; Blankenberg S; Barnes EH; Marschner IC; Thompson P; West M; Zeller T; Colquhoun DM; Nestel P; Keech AC; Sullivan DR; Hunt D; Tonkin A;
    J Am Heart Assoc; 2013 Oct; 2(5):e000360. PubMed ID: 24152981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation between lipoprotein-associated phospholipase A
    Zhou F; Liu Y; Shi H; Huang Q; Zhou J
    Neurol Sci; 2018 Sep; 39(9):1591-1596. PubMed ID: 29938341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) in acute coronary syndrome: relationship with low-density lipoprotein cholesterol.
    Jabor B; Choi H; Ruel I; Hafiane A; Mourad W; Genest J
    Can J Cardiol; 2013 Dec; 29(12):1679-86. PubMed ID: 24267807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lipoprotein-associated phospholipase A2 serum levels in patients from different categories of cardiovascular risk].
    Nozadze DN; Sergienko IV; Balakhonova TV; Semenova AE; Vlasik TN; Kukharchuk VV
    Kardiologiia; 2014; 54(3):57-63. PubMed ID: 25102750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated Lp-PLA2 levels add prognostic information to the metabolic syndrome on incidence of cardiovascular events among middle-aged nondiabetic subjects.
    Persson M; Hedblad B; Nelson JJ; Berglund G
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1411-6. PubMed ID: 17431184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein-associated phospholipase A2 for early risk stratification in patients with suspected acute coronary syndrome: a multi-marker approach: the North Wuerttemberg and Berlin Infarction Study-II (NOBIS-II).
    Möckel M; Müller R; Vollert J; Müller C; Danne O; Gareis R; Störk T; Dietz R; Koenig W
    Clin Res Cardiol; 2007 Sep; 96(9):604-12. PubMed ID: 17593313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe periodontitis is associated with the serum levels of hypersensitive C reactive protein and lipoprotein-associated phospholipase A2 in the patients of acute ischemic stroke.
    Chen C; Zhu J; Deng X; Yang Z; Lin W; Ma Y; Huang S; Chen L; Liu Y; Zhu F
    J Clin Neurosci; 2021 Jun; 88():232-236. PubMed ID: 33992190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein-Associated Phospholipase A2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease.
    Wallentin L; Held C; Armstrong PW; Cannon CP; Davies RY; Granger CB; Hagström E; Harrington RA; Hochman JS; Koenig W; Krug-Gourley S; Mohler ER; Siegbahn A; Tarka E; Steg PG; Stewart RA; Weiss R; Östlund O; White HD;
    J Am Heart Assoc; 2016 Jun; 5(6):. PubMed ID: 27329448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.